Pathstone Holdings
AIFF

Pathstone Holdings’s Firefly Neuroscience AIFF Stock Holding History

Pathstone Holdings’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,334
Closed -$86.5K – 2397
2024
Q1 		$86.5K Hold
8,334
– – ﹤0.01% 2232
2023
Q4 		$42.3K Buy
+8,334
New +$54.1K ﹤0.01% 2170

Other funds holding AIFF

WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return
TWM
Trueblood Wealth Management Lima, Ohio $286M AUM 27.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Pathstone Holdings's AIFF Position: Q2 2024 in Review

Pathstone Holdings sold out of Firefly Neuroscience (AIFF) in Q2 2024, closing a stake of 8,334 shares — an estimated $86.5K sold.

Pathstone Holdings first reported a position in AIFF in Q4 2023 and held it in 2 quarters. The position peaked at $86.5K in Q1 2024. 9 funds tracked by Wall St. Rank hold AIFF as of Q2 2024.

  • Pathstone Holdings reported no remaining Firefly Neuroscience position as of Q2 2024 after selling out during the quarter.
  • Pathstone Holdings sold 8,334 Firefly Neuroscience shares in Q2 2024, an estimated $86.5K.
  • Pathstone Holdings first reported a position in Firefly Neuroscience in Q4 2023 and held it in 2 quarters.
  • Pathstone Holdings's Firefly Neuroscience position peaked at $86.5K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2024.

Based on Pathstone Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.